Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
The Journal of Infectious Diseases
|
December 6, 2018
Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus)
David X Liu, Donna L Perry, Lisa Evans DeWald, et al.
Journal of AOAC International
|
August 22, 2017
AOAC SMPR 2016.017
Richard van Breemen, Joseph M Betz, Lisa Evans, et al.
Plos Neglected Tropical Diseases
|
July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Research Square
|
January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
Erica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Plos Neglected Tropical Diseases
|
April 14, 2017
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
Elizabeth A Nelson, Julie Dyall, Thomas Hoenen, et al.
Nature Communications
|
February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membrane
Kathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Microorganisms
|
April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
Courtney L Finch, Julie Dyall, Shuang Xu, et al.
The Journal of Infectious Diseases
|
June 26, 2018
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
Julie Dyall, Elizabeth A Nelson, Lisa Evans DeWald, et al.
Early Human Development
|
March 2, 2026
Corrigendum to "Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial" [Early Hum. Dev. 213 (2026) Page 1-5/P106442]
Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Early Human Development
|
December 1, 2025
Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial
Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
The Journal of Infectious Diseases
|
December 6, 2018
Persistence of Lassa Virus Associated With Severe Systemic Arteritis in Convalescing Guinea Pigs (Cavia porcellus)
David X Liu, Donna L Perry, Lisa Evans DeWald, et al.
Journal of AOAC International
|
August 22, 2017
AOAC SMPR 2016.017
Richard van Breemen, Joseph M Betz, Lisa Evans, et al.
Plos Neglected Tropical Diseases
|
July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin
Evelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Research Square
|
January 10, 2024
Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
Erica Saphire, Zhe Li Salie, Zunlong Ke, et al.
Plos Neglected Tropical Diseases
|
April 14, 2017
The phosphatidylinositol-3-phosphate 5-kinase inhibitor apilimod blocks filoviral entry and infection
Elizabeth A Nelson, Julie Dyall, Thomas Hoenen, et al.
Nature Communications
|
February 3, 2025
Anti-Ebola virus mAb 3A6 protects highly viremic animals from fatal outcome via binding GP<sub>(1,2)</sub> in a position elevated from the virion membrane
Kathryn M Hastie, Zhe Li Salie, Zunlong Ke, et al.
Microorganisms
|
April 3, 2021
Formulation, Stability, Pharmacokinetic, and Modeling Studies for Tests of Synergistic Combinations of Orally Available Approved Drugs against Ebola Virus In Vivo
Courtney L Finch, Julie Dyall, Shuang Xu, et al.
The Journal of Infectious Diseases
|
June 26, 2018
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
Julie Dyall, Elizabeth A Nelson, Lisa Evans DeWald, et al.
Early Human Development
|
March 2, 2026
Corrigendum to "Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial" [Early Hum. Dev. 213 (2026) Page 1-5/P106442]
Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Early Human Development
|
December 1, 2025
Universal maternal testing for group B streptococcus in late pregnancy: process outcomes and alongside qualitative study for the GBS3 trial
Jane P Daniels, Kate F Walker, Lucy Bradshaw, et al.
Page
of 6